The research results of the collaboration between the team led by Professor Wang Jian from the Laboratory Pulmonary Vascular Group and Professor Jason-XJ-Yuan of the Department of Translational Medicine at the University of Arizona, "Chloroquine is a Potent Pulmonary Vasodilator that Attenuates Hypoxia-induced Pulmonary Hypertension", was published on August 28, 2017 in British Journal of Pharmacology (BJP), the No.1 international journal of basic research in pharmacology, with an influence factor 5.491. The research reveals a new molecular mechanism for the treatment of various experimental pulmonary hypertension models with chloroquine, laying the theoretical foundation for its clinical application.